Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

COVID-19 Flexibility For Telehealth Payments Should Be Made Permanent, Telemedicine Group Tells CMS

Easing of reimbursements for more telehealth providers and more payments for use of remote patient monitoring sought

Executive Summary

The American Telemedicine Association backed use of more telehealth providers and changes to remote monitoring reimbursements in comments to the US Medicare agency.

You may also be interested in...



CMS Directors Urge Industry To Weigh In On MCIT Innovative Tech Proposal

Medicare agency reimbursement experts asked device technology firms to explain regulatory hurdles to getting proper reimbursements for their products in comments on an innovative technology rule.

AdvaMed White Paper Advises Systemic Medicare Coverage For Digital Technology

The medtech industry advocacy group issued a white paper on best methods for Medicare coverage of telehealth, remote patient monitoring and other digital technology.

CMS To Pay Clinicians For Telehealth Services During COVID-19 Outbreak

In a change likely to expand use of telemedicine, clinicians will be reimbursed for remote conversations and services to Medicare beneficiaries for the duration of the COVID-19 outbreak, CMS administrator Seema Verma said on 17 March.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT142829

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel